Literature DB >> 21490479

Understanding the value of antiangiogenic therapy in metastatic breast cancer.

Miguel Martín.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21490479     DOI： 10.1097/01.cco.0000397416.67622.10

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN： 1040-8746            Impact factor:   3.645


× No keyword cloud information.
  3 in total

1.  Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.

Authors:  Xuemei Jia; Fang Yu; Junfeng Wang; Stephen Iwanowycz; Fatma Saaoud; Yuzhen Wang; Jun Hu; Qian Wang; Daping Fan
Journal:  Breast Cancer Res Treat       Date:  2014-10-14       Impact factor: 4.872

2.  Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Authors:  Esak Lee; Jacob E Koskimaki; Niranjan B Pandey; Aleksander S Popel
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

3.  Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

Authors:  Melissa García-Caballero; Jenny Paupert; Silvia Blacher; Maureen Van de Velde; Ana Rodríguez Quesada; Miguel Angel Medina; Agnès Noël
Journal:  J Hematol Oncol       Date:  2017-06-19       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.